Compare SBCF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBCF | HAE |
|---|---|---|
| Founded | 1926 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2009 | 1996 |
| Metric | SBCF | HAE |
|---|---|---|
| Price | $31.92 | $77.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $38.00 | ★ $84.13 |
| AVG Volume (30 Days) | 612.5K | ★ 949.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | 0.29 | ★ 2.05 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $45.04 | N/A |
| Revenue Next Year | $6.30 | $5.23 |
| P/E Ratio | $108.00 | ★ $38.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.46 | $47.32 |
| 52 Week High | $35.55 | $87.32 |
| Indicator | SBCF | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 63.05 | 73.01 |
| Support Level | $29.30 | $48.98 |
| Resistance Level | $32.12 | $86.72 |
| Average True Range (ATR) | 0.62 | 3.04 |
| MACD | 0.22 | 1.24 |
| Stochastic Oscillator | 97.46 | 73.64 |
Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.